Skip to main content

Thrombin Generation Assays (TGAs)

  • Protocol
  • First Online:
Hemostasis and Thrombosis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1646))

Abstract

In recent years, there has been a revival of interest in a time-honored tool of the clotting trade: the thrombin generation curve or thrombin generation (TG) assay (TGA) as we now call it. Thrombin generation is a key coagulation process that determines the extent of a hemostatic plug or a thrombotic process. The recent development of newer tests based on the continuous registration of TG under in vitro conditions that mimic more closely what occurs in vivo prompted us to reinvestigate the balance between procoagulants and anticoagulants in patients. Measurement of TG is accepted as a research tool, but the variety of sources and concentrations of reagents, as well as technical constraints, limit its potential for proper clinical use. The newer TGAs not only provide an overall assessment of hemostasis but also provide promising laboratory tools for investigating hemorrhagic coagulopathies and monitoring replacement therapy in several clinical conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AMC:

7-Amino-4-methylcoumarin

BSA:

Bovine serum albumin

CaCl2 :

Calcium chloride

DMSO:

Dimethyl sulfoxide

HEPES:

2-{−4-(2-Hydroxyethyl]-1-piperazinyl}-ethanesulfonic acid, HNa buffer, HEPES/NaCl buffer

HNaBSA5:

HEPES/NaCl/0.5% BSA buffer

Max slope:

maximum slope (RFU I min)

NaCl:

Sodium chloride

PC:

Phosphatidylcholine

PL:

Phospholipid

PS:

Phosphatidylserine

RFU:

Relative fluorescence unit(s)

RT:

Room temperature

rTF:

recombinant tissue factor

TF:

Tissue factor

Time max slope:

time of maximum slope velocity (sec)

Z-Gly-Gly-Arg-AMC.HCI:

Benzyloxylcarbonyl-glycine-glycine-arginine-7-amido-4-methylcoumarin hydrochloride.

References

  1. Hemker HC, Willems GM, Beguin S (1986) A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 56:9–17

    CAS  PubMed  Google Scholar 

  2. Hemker HC, Beguin S (1995) Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 74:134–138

    CAS  PubMed  Google Scholar 

  3. Salvagno GL, Astermark J, Ekman M, Franchini M, Guidi GC, Lippi G, Poli G, Berntorp E (2007) Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation. Haemophilia 13:51–56

    Article  CAS  PubMed  Google Scholar 

  4. Salvagno GL, Astermark J, Lippi G, Ekman M, Franchini M, Guidi GC, Berntorp E (2009) Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia? Haemophilia 15:290–296

    Article  CAS  PubMed  Google Scholar 

  5. Berntorp E, Salvagno GL (2008) Standardization and clinical utility of thrombin-generation assays. Semin Thromb Hemost 34:670–682

    Article  CAS  PubMed  Google Scholar 

  6. Salvagno GL, Berntorp E (2010) Thrombin generation testing for monitoring hemophilia treatment: a clinical perspective. Semin Thromb Hemost 36:780–790

    Article  CAS  PubMed  Google Scholar 

  7. Váradi K, Negrier C, Berntorp E, Astermark J, Bordet JC, Morfini M, Linari S, Schwarz HP, Turecek PL (2003) Monitoring the bioavailability of FEIBA with a thrombin generation assay. J Thromb Haemost 1:2374–2380

    Article  PubMed  Google Scholar 

  8. Turecek PL, Váradi K, Keil B, Negrier C, Berntorp E, Astermark J, Bordet JC, Morfini M, Linari S, Schwarz HP (2003) Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 33:16–22

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Maj Ekman and Margoth Gunnarsson are acknowledged for providing excellent technical assistance. Funding was obtained from Lund University and Region Skane, Sweden.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gian Luca Salvagno M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Salvagno, G.L., Berntorp, E. (2017). Thrombin Generation Assays (TGAs). In: Favaloro, E., Lippi, G. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 1646. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7196-1_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7196-1_37

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7194-7

  • Online ISBN: 978-1-4939-7196-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics